Discover and read the best of Twitter Threads about #ehjacvc
Most recents (4)
Acute LDL-C reduction post ACS:
Strike early and strong!
A @escardio clinical consensus statement.
We believe it was time to add to "the lower the better" concept, the concept of "early and strong" LDL-C reduction after an ACS.
Why? A thread. 1/7
doi.org/10.1093/ehjacc…
Strike early and strong!
A @escardio clinical consensus statement.
We believe it was time to add to "the lower the better" concept, the concept of "early and strong" LDL-C reduction after an ACS.
Why? A thread. 1/7
doi.org/10.1093/ehjacc…
Current @escardio guidelines recommend a LDL-C goal of <55mg/dL & 50% reduction in all patients with established ASCVD and a step-wise approach to lipid-lowering therapy to get there.
2/7
doi.org/10.1093/eurhea…
2/7
doi.org/10.1093/eurhea…
The problem:
1) Observational data from several health systems consistently show failure in LDL-C goal achievement and intensification of lipid-lowering therapy.
2) Risk is particularly high in the early phase
3/7
doi.org/10.1001/jamaca…
10.1093/eurheartj/ehu505
1) Observational data from several health systems consistently show failure in LDL-C goal achievement and intensification of lipid-lowering therapy.
2) Risk is particularly high in the early phase
3/7
doi.org/10.1001/jamaca…
10.1093/eurheartj/ehu505
What is your take on #vasodilators in acute #HeartFailure? The upcoming November issue of #EHJACVC will bring you a PRO/CON "Vasodilator therapy in acute heart failure revisited"
As our PRO paper was published in advanced access, a sneak preview Tweetorial below...
@EHJACVCEiC
As our PRO paper was published in advanced access, a sneak preview Tweetorial below...
@EHJACVCEiC
First some background...
Current @escardio guidelines state (IIb, B): "In patients with AHF and a systolic blood pressure (SBP) >110 mmHg, intravenous vasodilators may be considered as an initial therapy to improve symptoms and reduce congestion."
Only 1 flowchart has them in...
Current @escardio guidelines state (IIb, B): "In patients with AHF and a systolic blood pressure (SBP) >110 mmHg, intravenous vasodilators may be considered as an initial therapy to improve symptoms and reduce congestion."
Only 1 flowchart has them in...
So far, I consider this a fair recommendation... In hyper/normotensive pulmonary oedema, they might be helpful in some cases, with their main benefit a reduced need for (non-)invasive ventilation!
Beautiful (older) trial by Gad Cotter on this: thelancet.com/journals/lance…
Beautiful (older) trial by Gad Cotter on this: thelancet.com/journals/lance…
Don't miss our monthly educational review #EHJACVC @ESC_Journals!
This month by the great @ArgaizR: fluids in #AKI
Co-starring: @ThinkingCC @khaycock2
Extremely proud that our journal offers a platform to 3 great clinicians & Twitter educators. I always learn from them...
This month by the great @ArgaizR: fluids in #AKI
Co-starring: @ThinkingCC @khaycock2
Extremely proud that our journal offers a platform to 3 great clinicians & Twitter educators. I always learn from them...
A strong argument is made to switch mainstream thinking in #AKI away from the fallacious concept of fluid responsiveness in all to a primary assessment of fluid tolerance.
Probably the most important thing I have learned on Twitter: #VExUS
Probably the most important thing I have learned on Twitter: #VExUS
Why do I like #VExUS so much? Because it really changed my everyday practice... Portal vein became part of my standard #echocardiography assessment.
And that's what we want to achieve with this review, offer something directly applicable at your bedside!
And that's what we want to achieve with this review, offer something directly applicable at your bedside!
1. Hot off the press - #EHJACVC Issue 1/2021 tweetorial 🔽
The issue opens with an editorial by new EiC @VranckxPascal, highlighting the aims of the journal, presenting the new editorial board and thanking @cvrints, former EiC academic.oup.com/ehjacc/article…
#ACVC_ESC #cardiotwitter
The issue opens with an editorial by new EiC @VranckxPascal, highlighting the aims of the journal, presenting the new editorial board and thanking @cvrints, former EiC academic.oup.com/ehjacc/article…
#ACVC_ESC #cardiotwitter
2. Issue focus: #CardiogenicShock (CS) management.
In the new "Sciencepulse", chaired by @ingo_ahrens, David Morrow from @BrighamWomens and @thiele_holger discuss differences and commonalities in CS management in Europe and North America academic.oup.com/ehjacc/article…
In the new "Sciencepulse", chaired by @ingo_ahrens, David Morrow from @BrighamWomens and @thiele_holger discuss differences and commonalities in CS management in Europe and North America academic.oup.com/ehjacc/article…
3. In an editorial titled "Potential growth in cardiogenic shock research though an international registry collaboration", @seanvandiepen and Dave Morrow call for a Hub-of-Spokes model in #CardiogenicShock research academic.oup.com/ehjacc/article…
#EHJACVC #CardioEd
#EHJACVC #CardioEd
